By obtaining the MIC of a drug against a specific bacterial strain and integrating pharmacokinetic/pharmacodynamic (PK/PD) principles, treatment regimens can be adjusted based on the dynamic changes in the patients infection status, thereby optimizing therapeutic efficacy and maximizing clinical benefits
One commenter indicated they had already spent more than the cost of the entire one-time burden estimate in just reviewing the proposed rule
Yin B-K, Lzaro D, Wang Z-Q
Abstract Background Alzheimers disease (AD) is the leading cause of dementia, characterized by a complex pathogenesis that complicates the development of effective treatments
Available at: Li H, Toh PZ, Tan JY, Zin MT, Lee CY, Li B, Leolukman M, Bao H, Kang L
In addition, ARA 290 treatment was associated with significantly reduced ratios of total serum cholesterol to high-density lipoprotein (HDL)-cholesterol ( p = 0.039